← Open Payments lookup

JOYCE AWUJOR: Open Payments

NPI 1063119832 · HAVRE DE GRACE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,246 in 83 payments from 16 companies in 2025. Trend: 2023 $577 · 2024 $2,036 · 2025 $2,246

Food & beverage: $2,246
CompanyPaymentsAmount
ABBVIE INC.15$357
Otsuka America Pharmaceutical, Inc.9$260
Neurocrine BioSciences, Inc.9$253
Janssen Pharmaceuticals, Inc7$251
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$238
Vanda Pharmaceuticals Inc.6$178
Axsome Therapeutics, Inc.4$172
E.R. Squibb & Sons, L.L.C.7$155
Supernus Pharmaceuticals, Inc.5$93
Alkermes, Inc.4$72

Products named: VRAYLAR, INVEGA SUSTENNA, INGREZZA, CAPLYTA, REXULTI, Auvelity, COBENFY, Qelbree.

Industry payments across MD — which companies pay providers there.